Parkside Financial Bank & Trust Emergent Bio Solutions Inc. Transaction History

Parkside Financial Bank & Trust

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$7.35 - $13.21 $3,454 - $6,208	470 New	470 $3,000
Q3 2022 Nov 01, 2022	BUY	$20.09 - $35.8 $1,727 - $3,078	86 Added 67.19%	214 $4,000
Q2 2022 Jul 13, 2022	SELL	$27.42 - $43.63 $850 - $1,352	-31 Reduced 19.5%	128 $4,000
Q1 2022 May 13, 2022	SELL	$36.48 - $52.22 $1,386 - $1,984	-38 Reduced 19.29%	159 $7,000
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $6,522 - $10,836	197 New	197 $9,000
Q3 2020 Nov 06, 2020	SELL	$81.91 - $134.94 $6,225 - $10,255	-76 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$54.33 - $89.52 $162 - $268	-3 Reduced 3.8%	76 $6,000
Q1 2020 May 05, 2020	BUY	$49.34 - $68.76 $888 - $1,237	18 Added 29.51%	79 $5,000
Q3 2019 Nov 05, 2019	BUY	$40.6 - $57.2 $446 - $629	11 Added 22.0%	61 $3,000
Q2 2019 Aug 06, 2019	BUY	$39.92 - $53.86 $958 - $1,292	24 Added 92.31%	50 $2,000
Q1 2019 May 01, 2019	SELL	$48.23 - $66.16 $241 - $330	-5 Reduced 16.13%	26 $1,000
Q4 2018 Jan 31, 2019	BUY	$55.63 - $73.24 $445 - $585	8 Added 34.78%	31 $1,000
Q3 2017 Oct 27, 2017	BUY	$34.14 - $40.45 $785 - $930	23	23 $1,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $463M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.